---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-007265"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:32:53.784701+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharma enters $2.07M ATM stock offering with Ladenburg Thalmann

## Summary
- At Market Issuance Sales Agreement with Ladenburg Thalmann for up to $2,070,463 of common stock.
- Ladenburg receives 3% commission on gross proceeds; Company reimburses up to $40,000 in expenses.
- Sales under existing S-3 effective Nov 20, 2023; prospectus supplement filed Sep 26, 2025.
- Company not obligated to sell any shares; no assurance of price, amount, or timing of sales.
- Agreement terminates upon sale of all shares or earlier per its terms.

## SEC filing metadata
- accession: 0001683168-25-007265
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007265/0001683168-25-007265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007265/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-007265
- JSON: https://secwatch.observer/filing/0001683168-25-007265.json
- Plain text: https://secwatch.observer/filing/0001683168-25-007265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.